Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$0.11 - $147.37 $728 - $976,326
6,625 Added 50.65%
19,706 $2,000
Q2 2022

Aug 16, 2022

BUY
$0.18 - $0.31 $2,354 - $4,055
13,081 New
13,081 $3,000
Q4 2021

Feb 15, 2022

SELL
$0.38 - $0.61 $16,520 - $26,519
-43,474 Closed
0 $0
Q3 2021

Nov 16, 2021

BUY
$0.58 - $0.69 $25,214 - $29,997
43,474 New
43,474 $28,000
Q3 2019

Nov 14, 2019

SELL
$0.45 - $1.73 $16,779 - $64,506
-37,287 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$0.28 - $3.1 $10,440 - $115,589
37,287 New
37,287 $63,000

Others Institutions Holding NBY

# of Institutions
1
Shares Held
2.94K
Call Options Held
0
Put Options Held
0

About NovaBay Pharmaceuticals, Inc.


  • Ticker NBY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,988,400
  • Market Cap $46.1M
  • Description
  • NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and Phase...
More about NBY
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.